Author:
Grau Juan J.,Zanon Gabriel,Caso Carlos,Gonzalez Xavier,Rodriguez Araceli,Caballero Miguel,Biete Albert
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. EUROCARE 4. Survival of cancer patients in Europe, 1995–2002: the EUROCARE 4 study. Edited by Riccardo Capocaccia et al. Eur J Cancer. 2009;45:901–1094.
2. National Comprehensive Cancer Network (NCCN). Practice guidelines in oncology, 2002. http://www.nccn.org . Accessed 1 Mar 2002.
3. Pestalozzi B, Castiglione M. Primary breast cancer: ESMO clinical recommentations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(Suppl 2):ii7–9.
4. Piñero A, Giménez J, Merck B, et al. Consensus meeting on sentinel lymph node biopsy in breast cancer. Spanish society of mastology and breast disease. Cir Esp. 2007;82:146–9.
5. Martin M, Villar A, Sole-Calvo A, et al. Doxorubicin in combination with fluorouracil and cyclophosphamide (iv FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (iv CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group. Ann Oncol. 2003;14:833–42.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献